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Aims: Hypoglycaemia unawareness is a common condition associated with increased risk of severe hypoglycaemia. The purpose of our study was 
to develop a simple to use, home-based and non-invasive hypoglycaemia warning system based on electroencephalography (EEG), and to 
demonstrate its use in a single-case feasibility study. 
Methods: A participant with type 1 diabetes forms a single-person case study where blood sugar levels and EEG were recorded. EEG was recorded 
using skin surface electrodes placed behind the ear located within the T3 region by the participant in the home. EEG was analysed retrospectively to 
develop an algorithm which would trigger a warning if EEG changes associated with hypoglycaemia onset were detected.  
Results: All hypoglycaemia events were detected by the EEG hypoglycaemia warning algorithm. Warnings were triggered with blood glucose 
concentration levels at or below 4.2 mmol/l in this participant and no warnings were issued when in euglycaemia. 
Conclusion: The feasibility of a non-invasive EEG-based hypoglycaemia warning system for personal monitoring in the home has been 
demonstrated in a single case study. The results suggest that further studies are warranted to evaluate the system prospectively in a larger group of 
participants. 
1. Introduction: Severe hypoglycaemia is a serious condition which
causes significant morbidity and mortality in patients with type 1 and 
type 2 diabetes [1]. As a precursor to severe hypoglycaemia, mild 
hypoglycaemia may give rise to a range of symptoms such as fatigue, 
dizziness, fast heart rate and confusion, but many patients are unaware 
of the condition, a phenomenon known as hypoglycaemia 
unawareness [1]. Patients with hypoglycaemia unawareness are at 
high risk of developing severe hypoglycaemia [2]. Early detection of 
mild hypoglycaemia could help prevent episodes of severe 
hypoglycaemia and improve overall glucose control.  
The current standard method for self-monitoring is an invasive blood 
test and there is need for a simple non-invasive monitoring technique 
which can be performed, as and when required by the person, in the 
home. Hypoglycaemia has a significant impact on the electrical 
signals of the brain, particularly in the low frequency bands such as 
the delta EEG band (0.5-4 Hz) of the electroencephalograph (EEG) 
signal [3,4]. This suggests the use of EEG for the detection of 
hypoglycaemic events [5]. A number of clinical studies have 
demonstrated the potential of EEG monitoring in this context [6, 7]. 
The purpose of our study was to develop a simple to use, home-based 
and non-invasive hypoglycaemia warning system based on EEG, and 
to demonstrate its use in a single-case feasibility study. 
2. Methods – Hypoglycaemia Warning System: The EEG recording
system utilised a bio-potential amplifier, microcontroller and battery 
power supply (Figure 1).   
The bio-potential amplifier (Texas Instruments, ADS1298) was 
configured to acquire a single differential EEG channel with 24 bit 
resolution and sample rate of 250 Hz. The microcontroller (XPS, 
LPC2368) logged the EEG channel to a SD memory card for 
subsequent analysis. Additional functionality enables signals also to 
be sent instantaneously via Bluetooth to compatible devices. 
Fig. 1 Portable EEG recording system. Functional block diagram 
(top) and photograph of the system (below). A single channel 
differential EEG signal was recorded as the potential difference 
between two electrodes (T3a-T3b). A further electrode provides the 
active ground connection to the person. 
3. Methods – Data Collection: Ethical approval was obtained for the
study from the University of Hull’s Faculty of Science Ethics 
Committee and a single participant with type 1 diabetes was recruited. 
The participant had type 1 diabetes for 8 years, was hypoglycaemia 
aware and had good glucose control with an HbA1c of 7.1 mmol/L. 
Following instruction in the use of the system the participant was 
invited to use the system as a self-monitoring tool in the home over a 
period of several days. Juhl et al [6] have already demonstrated that 
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subcutaneous electrodes positioned close to electrode position T3 on 
the International 10-20 System give a measurable response to 
hypoglycaemic events, so in this study similar electrode locations 
were utilised as illustrated in Figure 2.  Disposable sticky pad 
silver/silver chloride electrodes, typically used in electrocardiography, 
were used since they were easy and fast to apply by the participant. 
The participant could perform EEG recording as and when they 
wanted and no strict recording protocol was enforced apart from 
asking the participant to sample and record routine plasma glucose 
levels using an Accu-Chek Aviva Nano blood glucose monitor at 
intervals during EEG monitoring.  The participant was also asked to 
maintain a diary of symptoms during EEG recording. 
 
 
Fig. 2 Photograph of the electrode positions used in the study. EEG 
electrodes were positioned at T3a and T3b positions as illustrated. 
The active ground (Gnd) electrode was positioned on the ear lobe. 
 
4. Methods – Hypoglycaemia warning algorithm: EEG recordings 
were analysed retrospectively with the aim of developing an algorithm 
to provide a warning of potential hypoglycaemia. The algorithm was 
implemented and tested in Matlab. First, the EEG was band-pass 
filtered between 1 to 4 Hz to identify EEG changes principally within 
the delta band.  Amplitude changes in this band have been shown to 
be a sensitive marker for hypoglycaemia[3,4]. The detection algorithm 
analysed a 60 second rolling window of filtered EEG.  Within this 
window the number of times the EEG exceeded the amplitude 
threshold was counted and classed as an EEG event. The algorithm 
would issue a hypoglycaemia warning if the number of EEG events 
exceeded the count threshold.  The amplitude and count thresholds for 
this case were 0.1 mV and 50 events respectively. It is anticipated that 
these thresholds could be optimised for hypoglycaemia detection in 
specific subjects. 
 
5. Results: The participant performed self-monitoring on five 
occasions and the durations ranged from 20 to 87 minutes. Recordings 
were commenced in the early evening (recordings 1 to 4) or afternoon 
(recording 5) on five separate days whilst sitting down. The 
recordings are summarised in Table 1.  
Table 1: Details of the recordings undertaken by the participant. 
Recording Duration 
(minutes) 
Maximum 
blood 
glucose 
(mmol/l) 
Minimum 
blood 
glucose 
(mmol/l) 
Symptoms Warning 
issued 
by the 
EEG 
system 
1 87 8.3 4.2 None Yes 
2 79 6.0 4.9 None No 
3 56 7.3 3.4 Shaky Yes 
4 73 13.3 11.1 None No 
5 20 6.0 2.7 Shaky Yes 
 
From the above EEG recordings; example 10s segments of EEG 
recorded during euglycaemia (above 4.0 mmol/L) and hypoglycaemia 
(below 4.0 mmol/L) are illustrated in Figure 3 alongside their 
respective power spectral densities.  
 
Fig. 3 Delta-band filtered EEG of 10 s duration (top) and 
corresponding power spectral density (bottom) with normalised units 
(n.u.) of power during (A) euglycaemia (7.8 mmol/l) and (B) 
hypoglycaemia (4.2 mmol/l) captured from EEG recording 1 (see 
Table 1).  
 
Retrospective application of the hypoglycaemia warning algorithm to 
the recordings resulted in the generation of three warnings by the non-
invasive monitoring system (Table 1).  All warnings were confirmed 
to be coincident with low plasma glucose concentration readings.  
 
Figure 4 provides a representative example of the time-course of the 
monitor output in relation to the measured plasma glucose level 
during a monitoring period in which low levels of plasma glucose 
concentration were experienced by the participant.  
 
     
 
 
3 
Fig. 4 Retrospective time-course of the hypoglycaemia monitor output 
state (bottom trace) in relation to measured plasma glucose 
concentration levels (top trace with error bars indicating accuracy of 
glucose monitor) during a period of monitoring in which the 
participant experienced low levels of plasma glucose concentration. 
The monitor issued a warning coincident with the lowest 
concentration level (4.2 mmol/l). The error bars on the plasma 
glucose concentration level indicate the specified accuracy of the 
blood glucose monitor used within the study (± 20 % at glucose 
concentrations ≥ 4.2 mmol/l and ± 0.83 mmol/l at glucose 
concentrations < 4.2 mmol/l) [8]. 
 
6. Discussion: This study demonstrates the feasibility of an EEG-
based non-invasive hypoglycaemia warning system for personal 
monitoring in the home.  We have demonstrated the feasibility of the 
system to obtain EEG measurements using disposable sticky pad body 
surface electrodes, with the advantage that such electrodes are easily 
applied by the user.  
 
Combined with the low number of electrodes and ease of application 
our device utilised is a low-cost and portable EEG recording system 
which can either log EEG recordings onto a memory card for later 
analysis or send the EEG signal instantaneously via Bluetooth to 
compatible devices with potential use for real-time remote 
monitoring. The detection algorithm performed no complex 
mathematical calculations allowing the possibility of use on small 
portable devices, thus bringing a novel approach to hypoglycaemia 
alerts using wearable technology within the home with measurements 
performed by the user. 
 
The use of surface electrodes is in contrast to other similar studies 
using subcutaneous electrodes during clinical trials [6] which, 
although may provide EEG recordings with higher quality and fewer 
artefacts, are inconsistent with the aim of producing a simple and non-
invasive warning system which empowers the user to perform 
monitoring as and when required and with minimal risk of infection. 
Consistent with previous studies the EEG exhibited high amplitude 
slow waves during hypoglycaemia [3, 4, 6, 7, 9]. The EEG waveform 
changes associated with hypoglycaemic events accord with a study 
performed by Nguyen et al. which reported a significant increase in 
waveform power associated with hypoglycaemia within the Delta 
EEG band [7].   
 
We were able to retrospectively tune the parameters of the 
hypoglycaemia detection algorithm to provide an early warning of 
hypoglycaemia before the onset of symptoms (Table 1).  Blood 
glucose levels at or below 4.2 mmol/L were associated with warnings 
from the algorithm. The simple but effective warning algorithm 
utilises the changes in EEG amplitude due to hypoglycaemia to count 
events and subsequently; if a pre-defined threshold is met; trigger the 
hypoglycaemia warning. The warning algorithm is easily configurable 
to trigger at different levels by analysing a specified rolling time 
window, so could be tailored to individual users. The algorithm 
involves no high end processing or calculation on the EEG signal and 
therefore could be utilised in portable & low power devices. Hence 
the results of our study suggest that the home-based monitoring 
system has the potential to provide an early warning of 
hypoglycaemia and might be a useful tool to aid glucose control and 
prevent hypoglycaemia concurring with similar clinical trials of EEG 
hypoglycaemia detection with subcutaneous electrodes [9, 10].  
 
The paper presents an initial feasibility study with a view to 
expanding the research into full clinical trials across several patients 
subject to the appropriate Ethical approvals. To complete a full study 
further analysis of the data would be incorporated including 
performing a power calculation for the statistically appropriate 
number of participants and alsoSuch trials would need to consider the 
specific diabetic cohort to be selected in a full study (e.g. type I and/or 
type II diabetics) along with diabetic patient history and completing 
trials across varying environments and patient situations would need 
to be considered.  
 
Further trials would also test the robustness of the algorithm under a 
range of conditions which might arise in daily use, for example during 
talking and movement to gather further evidence beyond that of the 
initial study. A full study of this type was out with the scope of our 
preliminary investigation.  The results from our initial feasibility case 
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study will, however, enable support the undertaking of future clinical 
trials with a cohort of diabetic patients.  
Further studies would also test the device and developed algorithm’s 
application to home-based monitoring, because the system is based on 
mobile technologies, it has the functional capability to monitor 
remotely, away from the home.  
 
Additionally, although the system worked well in this case study it is 
essential that the results are shown to be repeatable in a large group of 
subjects and to demonstrate that the system is useful in preventing 
severe hypoglycaemic events and improves overall glucose control in 
subsequent clinical trials.  
 
7. Conclusion: The feasibility of non-invasive EEG-based 
hypoglycaemia warning system for personal monitoring in the home 
has been demonstrated in a single case study. The results suggest that 
further studies are warranted to evaluate the system in a larger group 
of subjects. 
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